Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aegerion to plead guilty to misbranding cholesterol drug, will pay $40 million
Aegerion to plead guilty to misbranding cholesterol drug, will pay $40 million
Aegerion to plead guilty to misbranding cholesterol drug, will pay $40 million
Submitted by
admin
on May 13, 2016 - 10:17am
Source:
BioPharma Dive
News Tags:
Aegerion
misbranding
Juxtapid
DOJ
SEC
Headline:
Aegerion to plead guilty to misbranding cholesterol drug, will pay $40 million
Do Not Allow Advertisers to Use My Personal information
